Proud Advocate for Justice and Mesothelioma Research
An advocate is “one who pleads the cause of another.” As lawyers,
we have fought for our client’s rights to compensation, but you
know as well as I do that
our client’s first priority is life. They want to live. They want to watch their grandchildren graduate. They want hope. We have
never met a client who said they would gladly trade their lungs for a
million dollars or even a trillion dollars.
An Advocate’s Perspective: Empower Mesothelioma Patients with Data-based Hope
In early 2008, our firm wrote an article laying out the choices and difficulties
faced by newly diagnosed mesothelioma patients. We suggested that patients
need more data and more hard information from surgeons and oncologists
regarding options. We also laid out the differences in reported survival
times for the two major surgical options, the
pleurectomy/decortication (P/D) and
extra-pleural pneumonectomy (EPP).
Roger was subsequently invited to make a presentation to the
International Mesothelioma Interest Group’s annual congress in Amsterdam on September 25, 2008.
Click here to view his speech and PowerPoint presentation, which focused on funding
for mesothelioma research and development of an online clinical database.
Mesothelioma Patient's Bill of Rights
We, the mesothelioma patients of the United States, in order to form a
more humane justice system, enhance domestic tranquility, provide for
quality of life, promote the healing process, respect the rights of the
injured to seek redress, and secure the blessings of liberty to ourselves
and our families, do propose this Mesothelioma Patients' Bill of Rights.
Action, Not Just Words
Worthington & Caron is about action, not just words. We have contributed
more than $3,765,000 to cancer research and science since 2000.
Roger Worthington was one of the founders of The Pacific Heart, Lung, & Blood Institute
(PHLBI) and the
Pacific Meso Center (PMC), which is a division of PHLBI.
Both centers are non-profit medical research organizations whose mission
is to improve the prevention,
diagnosis, and treatment of heart, lung, and blood diseases through independent
research, collaboration, and education. The Institutes have been designated
as an IRS 501(c)(3) tax-exempt organizations.
We are more than just committed attorneys.
We are committed advocates.